Home / Stocks / CUE

CUE insider trading

Cue Biopharma, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$131k
Buys · last 90 days
0 · $0
Most recent buy
2026-01-02

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-01-02Sarraf Pasha
Director
Bought323,857$0.31$100k
2024-12-18PASSERI DANIEL R
CHIEF EXECUTIVE OFFICER
Bought30,000$1.03$31k

Most active insider buyers

InsiderRoleBuysTotal bought
Sarraf PashaDirector1$100k
PASSERI DANIEL RCHIEF EXECUTIVE OFFICER1$31k

See CUE on the chart

Every insider buy and sell for CUE plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.